{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T16:31:52Z","timestamp":1791304312221,"version":"4.3.1"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Ther"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s40120-025-00857-0","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T08:05:01Z","timestamp":1763539501000},"page":"457-460","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Efgartigimod as Fast-Acting Rescue Therapy in Very Late-Onset Myasthenia Gravis"],"prefix":"10.1007","volume":"15","author":[{"given":"Nicasio","family":"Rini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flora","family":"D\u2019Amico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Portera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Brighina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9805-1655","authenticated-orcid":false,"given":"Vincenzo","family":"Di Stefano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,19]]},"reference":[{"key":"857_CR1","doi-asserted-by":"crossref","unstructured":"Gilhus NE. Myasthenia gravis. Longo DL, editor. N Engl J Med [Internet]. 2016 [cited 2022 Aug 6];375(26):2570\u201381. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/28029925\/.","DOI":"10.1056\/NEJMra1602678"},{"key":"857_CR2","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-019-09667-5","author":"J Rath","year":"2019","unstructured":"Rath J, Brunner I, Tomschik M, Zulehner G, Hilger E, Krenn M, et al. Frequency and clinical features of treatment-refractory myasthenia gravis. J Neurol. 2019. https:\/\/doi.org\/10.1007\/s00415-019-09667-5.","journal-title":"J Neurol"},{"key":"857_CR3","doi-asserted-by":"publisher","unstructured":"Claytor B, Cho SM, Li Y. Myasthenic crisis. Muscle Nerve [Internet]. 2023 [cited 2025 Oct 22];68(1):8\u201319. Available from: https:\/\/doi.org\/10.1002\/mus.27832.","DOI":"10.1002\/mus.27832"},{"key":"857_CR4","doi-asserted-by":"crossref","unstructured":"Evoli A, Antonini G, Antozzi C, DiMuzio A, Habetswallner F, Iani C, et al. Italian recommendations for the diagnosis and treatment of myasthenia gravis. Vol. 40, Neurological sciences. Springer-Verlag Italia s.r.l.; 2019. p. 1111\u201324.","DOI":"10.1007\/s10072-019-03746-1"},{"key":"857_CR5","unstructured":"Howard JF, Bril V, Vu T, Karam C, Peric S, Margania T, et al. Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial. Lancet Neurol [Internet]. 2021 [cited 2023 May 4];20(7):526\u201336. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/34146511\/."},{"key":"857_CR6","doi-asserted-by":"crossref","unstructured":"Zhang C, Li X, Deng Y, Luo H, Wang S, Yan X, et al. The efficacy and safety between efgartigimod and intravenous immunoglobulin in elderly generalized myasthenia gravis patients. Clin Immunol [Internet]. 2025 [cited 2025 May 15];274. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/39988290\/.","DOI":"10.1016\/j.clim.2025.110457"},{"issue":"12","key":"857_CR7","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1080\/1744666X.2022.2136167","volume":"18","author":"S Suzuki","year":"2022","unstructured":"Suzuki S, Uzawa A, Murai H. Efgartigimod for generalized myasthenia gravis with or without anti-acetylcholine receptor antibodies: a worldwide and Japanese perspective. Expert Rev Clin Immunol. 2022;18(12):1207\u201315.","journal-title":"Expert Rev Clin Immunol"},{"key":"857_CR8","doi-asserted-by":"publisher","unstructured":"Di Stefano V, Alonge P, Rini N, Militello M, Lupica A, Torrente A, et al. Efgartigimod beyond myasthenia gravis: the role of FcRn-targeting therapies in stiff-person syndrome. J Neurol [Internet]. 2023 [cited 2023 Sep 30];1:1\u20139. Available from: https:\/\/doi.org\/10.1007\/s00415-023-11970-1.","DOI":"10.1007\/s00415-023-11970-1"},{"key":"857_CR9","doi-asserted-by":"crossref","unstructured":"Vijayan J, Menon D, Barnett C, Katzberg H, Lovblom LE, Bril V. Clinical profile and impact of comorbidities in patients with very-late-onset myasthenia gravis. Muscle Nerve [Internet]. 2021 [cited 2022 Aug 6];64(4):462\u20136. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/34235762\/.","DOI":"10.1002\/mus.27369"},{"key":"857_CR10","doi-asserted-by":"crossref","unstructured":"Watanabe K, Ohashi S, Watanabe T, Kakinuma Y, Kinno R. Case report: Recovery from refractory myasthenic crisis to minimal symptom expression after add-on treatment with efgartigimod. Front Neurol. 2024 [cited 2024 Mar 17];15. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/38318438\/.","DOI":"10.3389\/fneur.2024.1321058"}],"container-title":["Neurology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40120-025-00857-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40120-025-00857-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40120-025-00857-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T13:52:07Z","timestamp":1768398727000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40120-025-00857-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,19]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["857"],"URL":"https:\/\/doi.org\/10.1007\/s40120-025-00857-0","relation":{},"ISSN":["2193-8253","2193-6536"],"issn-type":[{"value":"2193-8253","type":"print"},{"value":"2193-6536","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,19]]},"assertion":[{"value":"31 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"On behalf of all authors, the corresponding author states that Nicasio Rini, Flora D\u2019Amico, Valentina Portera, Filippo Brighina and Vincenzo Di Stefano have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"All human and animal studies have been approved by the appropriate ethics committee and have therefore been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. Patient informed consent was obtained and signed for the study and publication. All the authors of the present study were the patient\u2019s clinicians.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}